FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 43066-014 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBaxter Healthcare Corporation
Marketing categoryAbbreviated NDA (generic) · App ANDA078817
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20180219
Package count1

External sources

Source: openFDA. Public-domain (CC0).